C.H. Robinson Worldwide, Inc. filings document the regulatory record of a Delaware-based public logistics company listed on Nasdaq under CHRW. Its Form 8-K reports furnish quarterly financial results, earnings call materials, operating-income targets, share repurchase authorizations, and Regulation FD updates tied to its freight brokerage, forwarding, and transportation-management operations.
The company’s proxy materials cover board elections, director compensation, executive pay, shareholder voting matters, and governance practices. Other filings record board appointments and committee assignments, director departures, material agreements, and financing arrangements, including amendments to a receivables securitization facility involving C.H. Robinson Receivables, LLC. These disclosures also reflect capital-allocation actions, risk factors, ownership matters, and formal governance changes.
Rajan Arun, Chief Strategy & Innovation Officer of C.H. Robinson Worldwide, Inc. (CHRW), reported a sale of 2,500 shares of common stock on 08/15/2025 at a price of $121.74 per share. The filing states the sale was made pursuant to a 10b5-1(c) plan adopted on 05/08/2025. After the reported transaction, the reporting person beneficially owns 130,591 shares, which the filing explains include 91,210 shares issuable on settlement of restricted stock units and deferred shares credited to a NQDC plan account and 38,994 shares held directly; an additional 387 shares were acquired under the employee stock purchase plan. The form is signed by an attorney-in-fact and contains only the insider transaction and ownership breakdown disclosed above.
C.H. Robinson Worldwide, Inc. (CHRW) filed a Form 144 notifying the proposed sale of 2,500 common shares through Fidelity Brokerage Services with an aggregate market value of $304,350.00. The filing lists approximately 118,091,162 shares outstanding and an approximate sale date of 08/15/2025 on NASDAQ. The shares were acquired on 09/01/2022 upon restricted stock vesting from the issuer and were received as compensation. The filer reports no sales of the issuer's securities in the past three months. Several filer identification fields in the provided content (including CIK and contact details) appear blank in the copy provided.
Insider sale reported by Angela K. Freeman, CHRO and ESG Officer of C.H. Robinson Worldwide (CHRW). The Form 4 discloses that on 08/11/2025 Freeman disposed of 5,713 shares of CHRW common stock in multiple transactions at a weighted average price of $116.243 per share, with sale prices ranging from $116.11 to $116.48.
After the reported sale the reporting person beneficially owns 65,728 shares, comprised of 65,459 shares issuable upon settlement of restricted stock units and deferred plan credits and 269 shares held directly. No derivative securities were reported and the Form 4 was filed by one reporting person.
Edward G. Feitzinger, a director of C.H. Robinson (CHRW), was granted 1,270 restricted stock units (phantom shares) on 08/07/2025 as a pro-rated portion of the annual equity-based award for non-employee directors. Each unit will be paid in one share of common stock. The restricted stock units are immediately vested and, following the reporting person's termination of service as a director, become payable in shares according to the payment schedule previously chosen by the reporting person. The grant is reported as a direct acquisition of derivative securities at a $0 price.
C.H. Robinson Worldwide, Inc. director reports no share ownership. Edward G. Feitzinger, identified as a director of C.H. Robinson Worldwide, Inc. (CHRW), filed a Form 3 reflecting his status as a reporting person. The event date triggering this statement is listed as 08/07/2025. The filing states that no non-derivative or derivative securities are beneficially owned, and the remarks section confirms that no securities are beneficially owned. The form is filed by one reporting person, and a power of attorney is noted for the signature.
C.H. Robinson amended its receivables purchase agreement to extend the securitization facility's termination date to August 12, 2027, while the committed funding available to its bankruptcy-remote subsidiary, C.H. Robinson Receivables, LLC, remains unchanged at $500 million. This amendment preserves the company's existing receivables financing capacity and maintains an off-balance-sheet funding source used to support working capital and payments to freight carriers.
The report also supplements a prior disclosure that Edward G. Feitzinger was elected to the board and will receive the company’s standard non-employee director compensation per the 2025 proxy; committee assignments are not yet determined. The amendment is filed as Exhibit 10.1.
C.H. Robinson Worldwide, Inc. (CHRW) filed a Form 144 notifying a proposed sale of 5,713 common shares with an aggregate market value of $664,096.36. The notice identifies Fidelity Brokerage Services LLC as the broker and lists the approximate date of sale as 08/11/2025 on NASDAQ. The filing states total shares outstanding of 118,091,162.
The securities to be sold were acquired through employee stock purchase plan purchases on multiple dates (2019–2023) and restricted stock vesting in 2022 and 2024, with listed lots including 894 and 4,156 shares from vesting. The filing also reports a prior sale on 05/14/2025 of 5,700 shares by the Angela K Freeman Revocable Trust for $555,322.50.
Michael J. Short, President, Global Forwarding at C.H. Robinson (CHRW), reported exercising stock options to acquire 6,364 shares at an exercise price of $72.74 per share and selling 6,364 shares at a weighted-average price of $117.2415 on 08/06/2025. His reported beneficial ownership decreased from 66,765 shares to 60,401 shares. The filing notes 115 shares were acquired under the employee stock purchase plan and that 60,286 shares are issuable in settlement of restricted stock units and deferred plan credits to his NQDC account. The exercised options are fully vested.